3.0
Feb 27, 2019
Former employee
Recommend
CEO approval
Business Outlook
Pros
Good people (generally), good benefits, collegial atmosphere
Cons
Focus on Crop Science can distract from Pharma priorities. Patent cliff in 4-5 years will leave a huge revenue gap in Pharma with nothing currently in pipeline to fill it.